Emerging therapies have begun to evaluate the abilities of Müller glial cells (MGCs) to protect and/or regenerate neurons following retina injury. The migration of donor cells is central to many reparative strategies, where cells must achieve appropriate positioning to facilitate localized repair. Although chemical cues have been implicated in the MGC migratory responses of numerous retinopathies, MGC-based therapies have yet to explore the extent to which external biochemical stimuli can direct MGC behavior. The current study uses a microfluidics-based assay to evaluate the migration of cultured rMC-1 cells (as model MGC) in response to quantitatively-controlled microenvironments of signaling factors implicated in retinal regeneration: basic Fibroblast Growth factor (bFGF or FGF2); Fibroblast Growth factor 8 (FGF8); Vascular Endothelial Growth Factor (VEGF); and Epidermal Growth Factor (EGF). Findings indicate that rMC-1 cells exhibited minimal motility in response to FGF2, FGF8 and VEGF, but highly-directional migration in response to EGF. Further, the responses were blocked by inhibitors of EGF-R and of the MAPK signaling pathway. Significantly, microfluidics data demonstrate that changes in the EGF gradient (i.e. change in EGF concentration over distance) resulted in the directional chemotactic migration of the cells. By contrast, small increases in EGF concentration, alone, resulted in non-directional cell motility, or chemokinesis. This microfluidics-enhanced approach, incorporating the ability both to modulate and asses the responses of motile donor cells to a range of potential chemotactic stimuli, can be applied to potential donor cell populations obtained directly from human specimens, and readily expanded to incorporate drugeluting biomaterials and combinations of desired ligands.
Introduction
Retinal dysfunction and disease are leading causes of progressive and irreversible vision loss worldwide (Quigley and Broman, 2006) , (Wong et al., 2014) . Emerging studies have begun to evaluate the abilities of Müller glial cells (MGCs) to generate new neurons following retinal injury. MGC-mediated regeneration or neural cell delivery may thereby complement cell-replacement strategies using retinal progenitors and stem-like cells (Zhao et al., 2017; Santos-Ferreira et al., 2016; Klassen, 2016) . MGCs provide primary structural and trophic support for retinal neurons Willbold and Layer, 1998) and are known to react acutely to changes in the retinal microenvironment via migration, proliferation and expression of neurotropic factors (Lenkowski and Raymond, 2014; Tackenberg et al., 2009; Taylor et al., 2015) . Developing therapies have embedded MGCs within specialized biomaterial grafts (Becker et al., 2016; Bull et al., 2008; Lorber et al., 2015) and re-programmed MGCs into precursors of retinal neurons (Sanges et al., 2016; Das et al., 2006; Joly et al., 2011; Ooto et al., 2004; Singhal et al., 2012) to harness MGC neuroprotective responses that prevent neuronal death and isolate injured or diseased cells (Dreyfus et al., 1998; Machalinska et al., 2013) . The migration of MGC donors, thereby, becomes central to these reparative strategies, as cells must achieve appropriate positioning to facilitate localized repair (Santos-Ferreira et al., 2016; Thakur et al., 2018) .
Finely-tuned migration of donor cells undoubtedly includes chemotactic processes across concentration gradient fields of biochemical compounds (Reviewed in (Shellard and Mayor, 2016) ). Chemical cues from the retinal microenvironment have been implicated in MGC migratory responses of numerous retinopathies (Hollborn et al., 2005; Lorenc et al., 2015; Luo et al., 2016) , as MGCs have been reported in sub-retinal spaces adjacent to sites in need of repair (Tackenberg et al., 2009; Humphrey et al., 1993) , (Lee et al., 2008) putative receptors for many of the factors secreted by degenerating photoreceptors Dreyfus et al., 1998) . In addition, numerous projects have reported MGC migration in response to extrinsic growth factors, including EGF (Meuillet et al., 1996a) , HB-EGF (Hollborn et al., 2005; Hu et al., 2014; Inoue et al., 2013) , FGF (Romo et al., 2011) , TGFb (Luo et al., 2016) , IGF-1 (Lorenc et al., 2015) and VEGF (Gaddini et al., 2016) , as well as lipid receptors LRPI (Barcelona et al., 2013) and S1PR1 (Esche et al., 2010) . Surprisingly, many potentially MGC-reliant therapies have yet to explore the extent to which external biochemical stimuli can direct or regulate MGC migration to promote retinal repair.
Microfluidic systems provide opportunities for sensitive assessment of cell responses to sophisticated chemical gradients with and without extracellular matrixes (Reviewed in (Sackmann et al., 2014; Wu et al., 2013; Ricoult et al., 2015) ). Significantly, microfluidics enables precise control of concentration gradients that fundamentally drive chemotactic, or directional, migratory processes. This is particularly advantageous for modeling of retinal gradients, which are likely to be extremely steep and are developed over short anatomical distances (Goodhill, 2016) . The current study uses a microfluidic assay, called the μLane, to evaluate MGC migratory behaviors in response to quantitatively-controlled environments at the retinal microscale (Beck et al., 2016; Dudu et al., 2012; McCutcheon et al., 2017; Rico-Varela et al., 2015; Unachukwu et al., 2013 Unachukwu et al., , 2016 . This work examines the migration of a model MGC cell population in response to extrinsic signaling factors implicated in retinal regeneration: basic Fibroblast Growth factor (bFGF or FGF2) (Taylor et al., 2015; Meuillet et al., 1996b) ; Fibroblast Growth factor 8 (FGF8) (Fischer et al., 2009; Wan and Goldman, 2017) ; Vascular Endothelial Growth Factor (VEGF) (Gaddini et al., 2016; Saint-Geniez et al., 2008) ; and Epidermal Growth Factor (EGF) (Dreyfus et al., 1998; Hu et al., 2014) . The rMC-1 cell line was chosen to initially define the experimental system prior to investigations using primary Müller glia because the line is genetically wellcharacterized and expresses induced/basal markers of primary glia and receptors for critical signaling proteins (Jiang et al., 2006 (Jiang et al., , 2014 Muto et al., 2014; Yu et al., 2009) . Further, rMC-1 cells have been widelyused with animal studies in the development of retinal therapies (Qiu et al., 2017; Xu et al., 2015; Cui et al., 2012) .
Our findings indicate that rMC-1 cells exhibited minimal motility in response to FGF2, FGF8 and VEGF, but highly-directional migration in response to EGF. Further, the responses were blocked by inhibitors of EGF-R and of the MAPK signaling pathway. Interestingly, the chemotactic responses appeared to be preferentially activated by high EGF gradient fields, as migration in response to, both, moderate and lower EGF gradients elicited directionality and cell displacements comparable to control conditions (i.e. no EGF gradients). These results highlight the extent to which microfluidics-enhanced study can advance development of reparative therapies by manipulating cell migratory responses highly sensitive to properties of the chemotactic stimulus field.
Materials and methods

Cell culture
The rMC-1 cell line (Kerafast, Cat. No. ENW001) was maintained in Dulbecco's Modified Eagle Medium (DMEM) containing 4 mM L-glutamine, 4500 mg/L, 1 mM sodium pyruvate and 1500 mg/L sodium bicarbonate at 37C and supplemented with 10% fetal bovine serum (FBS) (Invitrogen-Gibco, Rockville, MD) in a 5% CO2 incubator. Cells were passaged with Accutase ® Solution (Sigma Life Science). For experiments, cells were initially seeded at 10 6 cells/mL per T-25 flask in medium containing 10% FBS, then cultured in serum-restricted medium containing 1% FBS for 2 weeks as per phenotypic guidelines (Sarthy et al., 1998) .
Cell morphology
Cell morphology was evaluated using Cell Shape Index (CSI), a dimensionless parameter that serves as a quantitative measure of asymmetry (Versaevel et al., 2012) , shown in Equation (1):
where A s and P represent cell surface area and perimeter, respectively. Values of CSI range from 1.0 for an idealized circular shape to near 0 for cells that are narrow and linearly elongated.
Immunocytochemistry
Cells were plated at 2 × 10 5 cells/mL on borosilicate glass well 
Transwell migration assays
Transwell assays were used to measure the number of cells that migrated towards different concentrations of growth factors, as described previously by our group (Rico-Varela et al., 2015) . The assay consisted of two compartments filled with medium and separated by an 8 micron-porous membrane (VWR, Cat. No.62406-198) . Cells were seeded in the upper compartment and were allowed to migrate through the porous membrane into the lower compartment for 18 h at 37°C, in 5% CO2 incubator. Approximately 1 × 10 6 cells/mL were seeded in 300 μl of DMEM complete medium (DMEM with FBS) in each upper chamber, while 700 μl of serum-free medium (DMEM only) was pipetted into each lower chamber. In addition, lower chambers had concentrations of the following growth factors: EGF (Sigma Aldrich, Cat. No. SRP3196) at 10, 100, and 500 ng/mL; FGF-8 (ThermoFisher, Cat. No. PHG0184) at 10, 100 and 1000 ng/mL; FGF-2 (Sigma Aldrich, Cat. No. SRP4039) at 10, 100 and 1000 ng/mL; and finally VEGF (Sigma Aldrich, Cat. No. SRP3182) at 10 and 100 ng/mL, which were diluted in DMEM. After incubation, cell numbers on the underside of the filter were estimated by staining using the Cyquant kit ® , which yields absorbance values proportional to DNA content.
Reverse transcription quantitative polymerase chain reaction (qPCR)
Quantitative PCR (qPCR) was used to measure expression levels of four receptor molecules and two glial cell markers: FGFR-2 (receptor for bFGF), FGFR-3 (receptor for FGF8), EGF-R (receptor for EGF), NRP-1 (the receptor for VEGF-A), as well as GFAP and Nestin (interfibrillar proteins of neural progenitors and/or glia (Bouameur and Magin, 2017) ). RNA was isolated from 3 separate thawed stocks of rMC-1 cells using Trizol (Sigma-Aldrich) and measured photometrically. First strand cDNA synthesis was performed using random hexamers followed by amplification with specific primers on a Rotor Gene 6000 thermal cycler (Qiagen, Inc.) as per manufacturer instructions. Primer sequences are shown in Table 1 using the following amplification conditions: 95C denaturation for 10 min, followed by 40 cycles of 95C for 15 s and 60C for 1 min, followed by a hold at 4C. Relative expression of the sample gene was calculated using the conventional ΔΔCT method (Livak and Schmittgen, 2001; Schefe et al., 2006; Schmittgen and Livak, 2008 ).
Cell migration in microfluidic μLane systems
The μLane system was developed to measure cell chemotaxis in response to precisely-defined concentration gradient fields, as described previously by our laboratory (Unachukwu et al., 2013; Kong et al., 2010 Kong et al., , 2011 . The μLane system consists of a 250-μm-diameter channel that connects two 170-μL volume reservoirs, as per Fig. 1(A and B) . The μLane inner surfaces were treated with 15 μg/mL of Collagen Type 1 (BD Biosciences, Bedford MA) for one hour at 37C. Note that rMC-1 cells were not observed to proliferate or migrate upon collagen surfaces for up to 48 h within microfluidic systems (data not shown). Cells were then loaded into the microchannel via the cell reservoir and growth factors were pipetted into the opposite reservoir before being placed in a stage-top incubator on a microscope stage for real-time imaging. Transport across the microchannel occurred via the well-established convective-diffusion processes of Equation (2), which has been modeled computationally and verified experimentally within the μLane as previously reported (Dudu et al., 2012; Unachukwu et al., 2016; Kong et al., 2010) :
where C is concentration, t represents time, u is velocity and D is molecular diffusivity. Transport produced a molecular distribution of ligand along the microchannel length with a range of concentration gradients at steady-state, where the concentration distributions no longer changed with time. At steady-state, EGF concentrations differ along the microchannel, as do EGF gradient fields, defined as the average difference in growth factor concentration (ng/mL) along defined sections of the microchannel length (mm) as shown in Equation (3):
where G represents concentration gradient, C is concentration and x represents axial distance along the channel length, l. In this study, three orders of concentration gradient were delineated along the microchannel as illustrated in Fig. 1 (C): 10 +1 < G H < 10 +3 ng/(mL.mm),
ng/(mL.mm) and 10 −3 < G L < 10
ng/ (mL.mm). The lowest gradient, G L , was nearest the source reservoir (growth factors only) and occupied approximately a 3-mm-length of microchannel, L L = 3 mm. As per Fig. 1 (C) , this is also the region of highest concentration, C(x). The largest gradient field, G H , was nearest the cell reservoir and occupied an approximate 2-mm-length of microchannel, L H = 2 mm. As before, this is the region of lowest concentration, C(x). The moderate concentration gradient G M occupied the central 7-mm-length of microchannel, i.e. distance in between the source and the cell reservoirs, L M = 7 mm. Note that gradients are highly non-linear within the system, similar to conditions documented in vivo (Goodhill, 2016) . Using this defined microfluidic environment, cell migration was evaluated using three primary parameters: (i) Total cell distance traveled (regardless of direction), also called path length;
(ii) Average cell velocity, i.e. average displacement of cell centroids along total path lengths; and (iii) Cell directionality, defined as the ratio of motile cells migrating in the gradient direction to the total number of motile cells (Kong et al., 2011; Mishra et al., 2015) . Lastly, all migration experiments were completed using 4-6 different batches of thawed cells within 4 different microdevices.
Imaging and analysis
Transmitted light microscopy images were obtained using an inverted microscope (Nikon TE2000) and a cooled CCD camera (CoolSNAP EZ CCD Camera, Photometrics, Tucson, AZ) with a 20× objective magnification (Nikon Plan 20×, Morrell Instrument Company Inc., Melville, NY). Fluorescent imaging was performed using Leica CLSM confocal microscope and a Zeiss LSM 710 confocal microscope, both at 63× magnification with oil immersion objective. Image processing was performed using ImageJ Chemotaxis and Migration Tool plugin (ImageJ 1.46r). Fluorescence intensity was measured using an average over the entire cell area for n > 25 cells per experiment in triplicate. Transmitted light image data was analyzed using Nikon software (Nikon Instrument Element 2.30 with 6D module, Morrell Instrument Company Inc., Melville, NY) and the ImageJ NIH shareware. Bright field images of motile cells were captured each hour for 12 h after steady state gradient fields had been established in the μLane system. These data were gathered at three identified section lengths of the microfluidic system (L H , L M and L L ) as per gradient fields in Fig. 1 . Lastly, the cell tracking software was used to generate plots of trajectories of motile cells.
Inhibition of EGF-R and MEK signaling pathway
EGF-R signaling and the downstream MEK signaling pathway were inhibited by Tarceva (Sigma Aldrich, Cat. No. CDS022564) and U0126 (Sigma Aldrich, Cat. No. U120) respectively to test their potential roles in mediating rMC-1 chemotaxis. Cells were seeded in Collagen Type 1 coated μLanes at 1.0x10 6 cells/mL in medium containing 1 μM Tarceva (Sigma Aldrich, Cat. No. CDS022564), 10 μM U0126 (Sigma Aldrich, Cat. No. U120) or control medium for 2 h at 37°C, as done previously by our group with cells of glial lineage in microdevices (Dudu et al., 2012) . Following the incubation period, cell migration in the μLane devices was recorded every 30 min for 8 h as described above.
Statistical analysis
Results were obtained in triplicate data sets from independent experiments and expressed as mean and standard deviation. Differences between groups were analyzed via One-way ANOVA and Post Hoc (Tukey) tests. ANOVA was performed to examine statistical significance across growth factors, while Tukey was performed to evaluate the differences between individual groups. Data with p-values < 0.05 were Table 1 Gene regulation examined via quantitative polymerase chain reaction (qPCR). A listing of the genes encoding the cell receptors molecules and interfibrillary proteins studied, alongside primer sequence (5′ to 3') and size in base pairs (bp). All tests were measured using GAPDH as the standard. 
Results
Müller glia phenotype and markers
Cultures of rMC-1 cells were first examined to evaluate the extent to which changes in cell morphology and proliferation rate simulated the phenotype of Müller glia in vivo. Experiments used the cell shape index, CSI, to illustrate that rMC-1 cells were initially rounded after t0 and resuspension, but developed elongated morphologies over time, both, in standard culture dishes and microfluidic systems. As shown in Fig. 2 , cells in dishes changed from a rounded morphology with CSI = 0.83 at 6 h post-seeding, to an elongated shape with CSI = 0.22 after 48 h. Cells cultured in μLane systems exhibited a similar pattern but over a longer time span. Cells at 6 h post-seeding illustrated CSI = 0.70 and did not fully elongate until 48 h with CSI = 0.20. Direct cell counting indicated that cell doubling time was approximately 72 h in culture dishes and 96 h in the μLane device. In addition, cultured rMC-1 cells stained positively for both GFAP and Nestin (intermediate filament protein markers of reactive Müller glia) distributed throughout the cytosol.
Receptor expression
In addition to GFAP and Nestin, rMC-1 cells expressed receptors for FGF-2, FGF-8, NRP-1 and EGF ligands as assessed via qPCR. Expression levels of these receptors were examined both under basal conditions and following treatment with EGF, as our group has previously reported marked increases in the EGF-R expression of glial progenitors after EGF treatment (Rico-Varela et al., 2015) . Under basal conditions (i.e. no external growth factor stimuli), all genes relative to the GAPDH standard were comparable within a factor of two. As seen in Table 2 , EGF treatment resulted in a statistically-significant, 2-fold upregulation of EGF-R and FGF-R2 mRNA levels, and downregulation of both FGF-R3 and NP1. However, while both Nestin and GFAP were upregulated via EGF treatment, only Nestin levels were statistically significant.
Motility in response to growth factors
Motility in response to signaling from different concentrations of FGF2, FGF8, EGF and VEGF ligands was first measured using conventional transwell assays. Fig. 3 illustrates that the numbers of cells which became motile in response to signaling from FGF-2 were similar to those seen in the control sample with no statistically significant differences across the 10-, 100-, and 1000-ng/mL concentrations of FGF-2 studied. The numbers of cells that became motile in response to signaling from 10-, 100-, and 1000-ng/mL concentrations of FGF-8 were lower than those of the control, as were cells stimulated by 10-and 100-ng/mL concentrations of VEGF. By contrast, large numbers of motile cells were measured in response to exogenous EGF signaling, with 2-fold that of the control in response to 10-ng/mL of EGF, 3-fold the control for 100-ng/mL EGF and 1.5-fold that of control for 1000-ng/mL EGF.
Migratory responses to controlled EGF concentration and gradient fields
The migratory response of rMC-1 to defined EGF fields was quantitatively evaluated using the μLane system. Fig. 4 illustrates representative cell migration paths optically tracked within high, moderate and low gradient fields within different section lengths, l, of the μLane:
Note that each gradient field is a non-linear variant of concentration per length, as per Equation (3). The starting point of each cell path was positioned at the origin (0,0) in each plot. Cells migrated toward increasing EGF concentrations, albeit with different path distances, gradient sensitivities and directionality. Average values of distance traveled (i.e. total path length), net displacement and directionality per gradient field are summarized in Table 3 , with asterisks that highlight significant differences against control (no EGF gradients). As seen in Fig. 5 , the highest EGF concentration gradients, G H , resulted in the largest migration distances and the greatest directionality, each with statistical significance against control. Chemotactic responses to moderate gradients, G M , exhibited less distance traveled with less directionality than G H , but maintained statistical significance against control. Cells exposed to the lowest EGF gradients, G L , demonstrated little directionality, with movement largely confined to small displacements (< 20 μm) about the origin in all directions, with no statistical significance against control. Note that cells in control experiments not exposed to EGF fields illustrated highly non-directional movement and the lowest accumulated distances.
Lastly, μLane systems were used to assess potential EGF signaling pathways that mediated rMC-1 chemotaxis. Cells were seeded into μLane systems containing defined G H , G M and G L fields of EGF as before, and then treated with either the EGF-R inhibitor, Tarceva, or the MEK inhibitor, U0126. As seen in Fig. 6 , both compounds blocked migration of cells in response to EGF, reducing the total migration distance in all cases to levels below that seen in the absence of EGF (i.e. controls).
Discussion
This study examined the migration of a model MGC cell line, rMC-1, in response to signaling from bFGF, FGF8, VEGF and EGF ligands implicated in, both, retinal development and regeneration (Ooto et al., 2004; Dreyfus et al., 1998 ). Our results demonstrate that EGF is a positive chemotactic regulator of rMC-1, in vitro, and modulates other phenotypic features including expression of its own receptor, EGF-R, receptors of other known regulators of MGCs, i.e. FGF-R2 and FGF-R3, and markers associated with MGC de/differentiation from stem-like cells, i.e. Nestin and GFAP.
Of the four ligands examined, only EGF produced positive cell migration compared to control using classical transwell migration assays (Fig. 3) . The rMC-1 cells exhibited a dose-dependent response, as reported previously with Müller glia derived from multiple species (Beach et al., 2017) . Study via qPCR also illustrated an upregulation of Nestin in response to EGF stimulation. This result supports recent results by Lee et al. (2012) that suggest Nestin markers may be used to correlate movement of Müller glia with states of de-differentiation and/or (Takeuchi et al., 2014; Hollborn et al., 2006) . However, PCR data illustrated that EGF was able to influence the expression of cognate receptors for each ligand, upregulating FGF-R2 and EGF-R while strongly downregulating FGF-R3 and NRP-1 (Table 2) . Thus, the responsiveness of rMC-1 cells (and potentially native MGCs) may depend on the combined actions of several paracrine regulators. While experiments did not examine the extent to which EGF can alter migratory responses of other ligands, such combinatorial regulation of retinal cells warrants future study. Experiments next adapted the μLane system ( Fig. 1) to evaluate cell migration in response to finely-controlled EGF gradients on the retinal microscale. The μLane offers abilities to not only create and measure cellular responses, but more significantly, to differentiate effects of EGF gradients from those of EGF concentration; a capability not available with conventional systems (Rico-Varela et al., 2015; Kong et al., 2011; Able et al., 2012) . For example, commonly-used scratch assays depend upon the formation of cell monolayers for testing, and are, thereby, fundamentally influenced by the properties of the extracellular matrix the cells produce (Reviewed in (Ashby and Zijlstra, 2012) ). Further, scratch assays by nature induce acute damage to motile cells and assess migration over a damaged substratum that poorly represents the complex matrixes present in native or transplantable retinal biomaterials (Thakur et al., 2018) . Transwell migration performed using modified Boyden chamber-type assays facilitates better control of cell substratum than scratch assays, with the added benefit of controlled chemical environments. However, neither assay can evaluate cell motility in terms of concentration gradients that fundamentally drive chemotactic processes. By contrast, experiments using the μLane were able to illustrate that high EGF gradients, G H , produced highly directional cell migration (Fig. 5) . Cell distances traveled (or path lengths) were largest for motile cells within G H fields, where net cell displacement was 3-fold greater than all other concentration gradient fields (Table 3) . Additionally, high concentrations of EGF, C (x = L H = 1.2 cm), where gradients were substantially lower, G L , yielded, both, lower migration distance and directionality. Note that migration experiments occurred prior to measured proliferation times within μLane devices. In complement, rMC-1 cells exhibited low displacement and directionality in low gradient fields, G L , despite higher concentration, C (x = L L = 0.2 cm), in those microchannel regions (Fig. 1) . These data illustrate dominate migratory effects of gradient changes, G, as opposed to changes in concentration, C, which distinguishes directional chemotaxis from the non-directional motility of chemokinesis (Shellard and Mayor, 2016) . Our group has observed similar migratory behavior from glial progenitors derived from a medulloblastoma cell line (Dudu et al., 2012; Rico-Varela et al., 2015) , but opposite behavior from primary and derived neuronal progenitors (Beck et al., 2016; Able et al., 2012) . Such differences require the use of primary Müller glia in future studies to elucidate native cell responses in vitro.
Lastly, EGF-R mediated migration of rMC-1 was shown to act principally via the MAPK signaling pathway, as migration was greatly reduced in the presence of the MEK inhibitor, U0126 (Fig. 6) . Further, experiments were performed prior to cell proliferation times, and all cells remained adhered and with unchanged morphology (as per CSI) to indicate viability. Data indicate that cell migration was virtually eliminated by compounds that inhibited the function of the EGF-R, and of the principal MAPK transduction pathway implicated in EGF-dependent chemotactic responses, previously suggested as neuroprotective (Hu et al., 2014) . These results indicate that cell migratory behavior in the μLane device is dependent on expected mechanisms, and that the system can be used to dissect more closely how those mechanisms operate in response to precisely-defined variations in chemotactic stimuli. These powerful results highlight sensitive gradient responsiveness of rMC-1 cells to its chemical microenvironment, a property that has been only partially explored for reparative therapies using Müller glia.
In summary, we demonstrate that basal and chemotactic migration of rMC-1 cells may be modeled and analyzed in vitro via an experimental system that facilitates application of finely-tuned stimuli and precise analysis of cell responses. Moreover, the dimensional features of the microdevice can be more easily related to the features of native tissues or transplants/implants with artificial scaffolds and ECM components. Our microfluidics-enhanced approach can be readily expanded to incorporate drug-eluding biomaterials (Beeley et al., 2006) , ligand combinations (Unachukwu et al., 2016) , and a variety of retinal replacement cells (Zhao et al., 2017) , potentially including primary human Müller glia. The detailed and precise information available from this approach should provide improved guidelines for development of grafts or other cell-based retinal therapies. 
